Jayvik Pharma Private Limited
About Jayvik Pharma Private Limited
Data last updated:
Jayvik Pharma Private Limited is a private limited company based in Dhule, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 11 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51900PN2017PTC172965. Its GSTIN is 27AAECJ0962H1ZK (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lalit Anandidas Shah and Jayesh Lalit Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ghar No.3025 Agra Road, Dhule, Maharashtra, India – 424001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.93 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹42,919 (net margin -7.2%) and EBITDA of -₹34,197 (EBITDA margin -5.8%). Revenue has grown at a compounded annual rate (CAGR) of 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGhar No.3025 Agra Road, Dhule, Maharashtra, India – 424001
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Jayvik Pharma Private Limited
The main business activity of Jayvik Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Jayvik Pharma Private Limited FY 2025 filings available
Jayvik Pharma Private Limited reported revenue of ₹5.93 Lakh (up 375% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Jayvik Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 375% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Jayvik Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹34,197 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹42,919 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Jayvik Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -7.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jayvik Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Jayvik Pharma Private Limited
Jayvik Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SSPM Ayurvedic Private Limited | ₹6 Lakh (FY 2025) | •••• | •••• | 122.0% | •••• | Hyderabad, Telangana, India |
| Vimalsa Overseas Private Limited | ₹5.98 Lakh (FY 2025) | •••• | •••• | •••• | Sumerpur, Rajasthan, India | |
| Zerachiel Healthcare Private Limited | ₹5.96 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | Lucknow, Uttar Pradesh, India |
| Maa Vaishno Tools & Machines Private Limited | ₹5.95 Lakh (FY 2025) | •••• | •••• | 73.0% | •••• | Bhopal, Madhya Pradesh, India |
| F D M Trading India Private Limited | ₹5.94 Lakh (FY 2025) | •••• | •••• | -93.0% | •••• | Delhi, India |
| Jayvik Pharma Private Limited this company | ₹5.93 Lakh (FY 2025) | •••• | •••• | 375.0% | •••• | Dhule, Maharashtra, India |
| Lucida Pharmaceuticals Private Limited | ₹5.9 Lakh (FY 2025) | •••• | •••• | -33.0% | •••• | Aurangabad, Maharashtra, India |
| Shalimar Electro Tech Private Limited | ₹5.89 Lakh (FY 2025) | •••• | •••• | -68.0% | •••• | New Delhi, Delhi, India |
| Vasundhara Commodities Pvt Ltd | ₹5.88 Lakh (FY 2025) | •••• | •••• | 2842.0% | •••• | Nagpur, Maharashtra, India |
| Sarvottam Engineering Solutions Private Limited | ₹5.87 Lakh (FY 2024) | •••• | •••• | 4521.0% | •••• | Delhi, India |
| Spherenet Technologies Private Limited | ₹5.87 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Jayvik Pharma by revenue in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Jayvik Pharma Private Limited
Jayvik Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalit Anandidas Shah | Director | 11 Oct 2017 | 8 Years 11 Months | Current |
| Jayesh Lalit Shah | Director | 11 Oct 2017 | 8 Years 11 Months | Current |
Ownership and Shareholding of Jayvik Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Jayvik Pharma Private Limited
Jayvik Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Jayvik Pharma Private Limited
Employment history and EPFO contributions of people linked to Jayvik Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Jayvik Pharma Private Limited
Jayvik Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Jayesh Lalit Shah was appointed as Director on 11 Oct 2017.
Credit Ratings, Litigation & Regulatory Alerts for Jayvik Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Jayvik Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jayvik Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Jayvik Pharma Private Limited
Jayvik Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECJ0962H1ZK | Maharashtra | Active | 04 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jayvik Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayvik Pharma Private Limited
Jayvik Pharma is an active private limited company based in Dhule, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 11 October 2017 (9+ years old) and is registered under CIN U51900PN2017PTC172965.
Jayvik Pharma reported revenue of ₹5.93 Lakh for FY 2025 (up 375% YoY).
Jayvik Pharma has 2 current directors:
- Lalit Anandidas Shah - Director
- Jayesh Lalit Shah - Director
Jayvik Pharma reported a net loss of ₹42,919 (net margin -7.2%) and EBITDA of -₹34,197 (EBITDA margin -5.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Jayvik Pharma is 14% over five years. In the latest year (FY 2025) revenue rose 375%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Jayvik Pharma is 27AAECJ0962H1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Jayvik Pharma is U51900PN2017PTC172965. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jayvik Pharma was incorporated on 11 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Jayvik Pharma by revenue are SSPM Ayurvedic Private Limited, Vimalsa Overseas Private Limited, Zerachiel Healthcare Private Limited, Maa Vaishno Tools & Machines Private Limited, F D M Trading India Private Limited and 5 more, all in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles).
Jayesh Lalit Shah was appointed as Director on 11 Oct 2017. Lalit Anandidas Shah was appointed as Director on 11 Oct 2017.
The registered office of Jayvik Pharma is at Ghar No.3025 Agra Road, Dhule, Maharashtra, India – 424001.